经尿道等离子双极电切治疗高危良性前列腺增生200例体会

目的：探讨经尿道等离子双极电切治疗高危前列腺增生的安全有效性。方法：采用经尿道等离子双极电切治疗高危前列腺增生患者200例。术后随访1～6 个月，比较术前术后的前列腺症状评分、生活质量评分、最大尿流率、残余尿量。结果：所有患者均安全耐受手术并出院，术中生命体征平稳，手术时间30～95 min，切除腺体25～80 g，术中平均出血约60 ml，无输血患者，无电切综合征及因手术加重其他脏器并发症发生，所有患者术后排尿通畅，最大尿流率等各项指标均较术前明显好转。结论：经尿道等离子双极电切用于治疗高危前列腺增生，是一种安全、有效的微创手术方法。

Clinical experiences of 200 cases of high-risk benign prostate hyperplasia treated by transurethral prostectomy with the bipolar plasmakinetic technique

Objective： To evaluate the effect and safety of transurethral prostectomy with the bipolar plasmakinetic technique （PKRP） in the treatment of high-risk benign prostate hyperplasia （BPH）. Methods： 200 cases of high-risk BPH patients underwent PKRP. Patients were followed up 1 to 6 months, compared before and after operation of prostate symptom score （I-PSS）, quality of life score （QOS）, maximum flow rate （Qmax）, residual urine volume. Results： All patients tolerated surgery safely, and discharged with stable vital signs surgery, operative time 30 to 95 min, removal of the gland 25 to 80 g, mean blood loss of about 60 ml, no blood transfusion cases, no TURP syndrome, and no increase due to surgery other organ complications, postoperative voiding in all cases, the maximum flow rate and other parameters were significantly improved preoperatively. Conclusion： PKRP is a safe and effective minimally invasive means for the treatment of high-risk BPH.